Research Registration Management System
The Research Registration Management System is a centralized, highly configurable platform designed to model, record, and track a wide range of biologic and chemical entities—including biomolecules, proteins, conjugates, and synthetic compounds—by managing their lineage, uniqueness, and provenance, enabling flexible registration through various interfaces, integrating with Dotmatics applications for streamlined workflows, and safeguarding intellectual property through accurate and timely data management.
Lineage and Uniqueness Tracking
Model, record, and track biologic entities such as biomolecules, proteins, or bioconjugates and their lineages. This includes chemically-modified sequences, sequence-less entities, and sequence designs, allowing determination of uniqueness for registration.
Centralized Data Management System
Utilize a central, formalized system for managing critically valuable research data, including therapeutic candidates. This system protects intellectual property and improves data fidelity.
Register a Broad Range of Biologics
The system supports registration of entities such as DNA, RNA, peptides and proteins, antibodies, conjugates, non-natural peptides and nucleotides, plasmids, cell lines, and user-defined entities.
Chemical and Reagent Sample Registration
Quickly log chemical structures and associated data for newly synthesized or acquired compounds.
Uniqueness Determination
Establish the uniqueness of compounds and assign new corporate IDs and/or new batch and lot IDs.
Flexible Registration
Register single compounds or batches using a company’s internal user interface, Dotmatics, or a third-party platform.
Entity Registration Across Biology and Chemistry
- Highly Configurable Lab Automation: Create and modify entity definitions, define subtypes with different attributes, set custom uniqueness rules, configure workflows, and more.
- Track Provenance and Relationships: Maintain records of entity lineage and relationships between associated entities, including entity-batch-sample hierarchies.
- Bidirectional Data Access: Integration with other Dotmatics applications enables quick and easy access to registration data, streamlining laboratory workflows.
- Protect Intellectual Property: Timely and accurate registration safeguards proprietary materials for biologics and chemical discovery organizations.
- Sequence Design Management: Generates full chemical representation, where possible, for natural and non-natural entities.
- Protein Production Management: Centralized data tracking and storage for the entire protein production process, including expression vectors and levels, protein tags, purification protocols, and protein concentrations and purities.
- Easy to Access: The platform links with third-party applications and is web-based to support quick access and collaboration.
Related
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.
Next Generation Biologics R&D
Christian Olsen of Dotmatics highlighted at the BioIT-World Expo how their flexible end-to-end R&D platform overcomes challenges in biologics discovery—such as fragmented, diverse, and siloed data from multiple complex analytical methods like sequencing, mass spectrometry, and flow cytometry—by unifying data and tools to enable multidimensional candidate profiling, streamline workflows, and accelerate preclinical biologics research.
Dotmatics Electronic Laboratory Notebook (ELN)
Dotmatics Electronic Laboratory Notebook (ELN) is a secure, cloud-hosted, and intuitive virtual notebook designed by scientists to streamline capturing, storing, searching, and sharing diverse scientific experiments and data types across disciplines, featuring flexible protocols, intelligent dashboards, integration with Dotmatics applications and third-party databases, and support for internal and external collaboration to enhance productivity and data-driven decision making.
Why Unified Software and Data Flows Are the Future of Biologics Discovery
The article discusses how biologics are revolutionizing disease treatment with numerous recent drug approvals across diverse modalities and conditions, highlighting that the future of biologics discovery lies in unifying software tools and data flows to manage complex, voluminous data and enhance research workflows through integrated, seamless analysis and visualization platforms.
From Fragmented Data to Unified Discovery: LifeArc's Approach to Multimodal R&D
LifeArc, a UK-based medical charity focused on transformative life science, has developed a collaborative, multidisciplinary R&D approach that integrates diverse data from over 100 internal scientists, external pharma, biotech, academic partners, and CROs across multiple therapeutic modalities—including small molecules and biologics like engineered antibodies—to streamline drug discovery and design for diseases such as cancer, Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and COVID-19, enabling unified data flow and informed, data-driven decision-making that has already resulted in four licensed medications and several drugs in trials.
Techstrong TV: AI Leadership Insights for Scientific Research and Drug Discovery
In this Techstrong TV interview, Dotmatics CEO Thomas Swalla discusses how the company leverages AI to accelerate scientific research and drug discovery by streamlining workflows, enabling breakthroughs, and reducing costs in R&D.